| Name | 5-HT2 antagonist 1 |
|---|---|
| Synonyms |
5-{3-[4-(4-Fluorophenyl)-1-piperazinyl]propyl}-8-hydroxy-1-methyl-5,6,7,8-tetrahydropyrrolo[3,2-c]azepin-4(1H)-one
Pyrrolo[3,2-c]azepin-4(1H)-one, 5-[3-[4-(4-fluorophenyl)-1-piperazinyl]propyl]-5,6,7,8-tetrahydro-8-hydroxy-1-methyl- |
| Description | 5-HT2 antagonist 1 is a potent antagonist of 5-HT2 receptor, with weak α1 adrenoceptor blocking activity. |
|---|---|
| Related Catalog | |
| In Vitro | 5-HT2 antagonist 1 shows 45%, 88%, 93% inhibition of 10 μM erotonin-induced contraction at 10 nM, 100 nM, 1000 nM, respectively, in guinea pig mesentcric artery. 5-HT2 antagonist 1 causes 1% and 10% inhibition of 10 μM norepinephrine-induced contraction at 10 and 100 nM, respectively, in guinea pig aorta[1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 613.9±55.0 °C at 760 mmHg |
| Molecular Formula | C22H29FN4O2 |
| Molecular Weight | 400.490 |
| Flash Point | 325.1±31.5 °C |
| Exact Mass | 400.227448 |
| LogP | 0.83 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.629 |